Apparatus and methods for coating medical devices

Information

  • Patent Grant
  • 11628466
  • Patent Number
    11,628,466
  • Date Filed
    Tuesday, November 26, 2019
    5 years ago
  • Date Issued
    Tuesday, April 18, 2023
    a year ago
Abstract
Embodiments of the invention include apparatus and methods for coating drug coated medical devices. In an embodiment, the invention includes a coating apparatus including a coating application unit. The coating application unit can include a fluid applicator having a lengthwise axis and a width. The fluid applicator can include a tip comprising a first face across the width of the fluid applicator. The first face of the fluid applicator can be oriented at an angle of from about 15 to about 75 degrees with respect to the lengthwise axis of the fluid applicator. The fluid applicator can define a second face intersecting the first face. The coating apparatus can further include a rotation mechanism and an axial motion mechanism. Other embodiments are also included herein.
Description
FIELD OF THE INVENTION

The present invention relates to apparatus and methods for coating medical devices.


BACKGROUND OF THE INVENTION

Functional improvements to implantable or insertable medical devices can be achieved by coating the surface of the device. For example, a coating formed on the surface of the device can provide improved lubricity, improved biocompatibility, or drug delivery properties to the surface. In turn, this can improve movement of the device in the body, extend the functional life of the device, or treat a medical condition near the site of implantation. However, various challenges exist for the design and use of coating apparatus designed to provide coatings to medical devices.


Traditional coating methods, such as dip coating, are often undesirable as they may result in flawed coatings that could compromise the function of the device or present problems during use. These methods can also result in coating inaccuracies, which can be manifested in variable amounts of the coated material being deposited on the surface of the device. When a drug is included in the coating material, it is often necessary to deliver precise amounts of the agent to the surface of the device to ensure that a subject receiving the coated device receives a proper dose of the agent. It has been difficult to achieve a great degree of accuracy using traditional coating methods and machines.


SUMMARY OF THE INVENTION

Embodiments of the invention include apparatus and methods for coating drug coated medical devices. In an embodiment, the invention includes a coating apparatus including a coating application unit. The coating application unit can include a fluid applicator having a lengthwise axis and a width. The fluid applicator can include a tip, the tip comprising a first face across the width of the fluid applicator. The first face of the fluid applicator can be oriented at an angle of from about 15 to about 75 degrees with respect to the lengthwise axis of the fluid applicator. The fluid applicator can define a second face intersecting the first face. The coating apparatus can further include a rotation mechanism and an axial motion mechanism. The axial motion mechanism can be configured to cause movement of at least one of the coating application unit and the rotation mechanism with respect to one another.


In an embodiment, a method of coating a medical device is included. The method can include rotating a medical device to be coated with a rotation mechanism. The method can further include contacting the surface of the medical device with a fluid applicator having a lengthwise axis and a width, the fluid applicator comprising a tip, the tip comprising a first face across the width of the fluid applicator. The first face can be oriented at an angle of from about 15 to about 75 degrees with respect to the lengthwise axis of the fluid applicator. The fluid applicator can define a second face intersecting the first face. The method can further include applying a coating solution onto the surface of the balloon with the fluid applicator.


This summary is an overview of some of the teachings of the present application and is not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details are found in the detailed description and appended claims. Other aspects will be apparent to persons skilled in the art upon reading and understanding the following detailed description and viewing the drawings that form a part thereof, each of which is not to be taken in a limiting sense. The scope of the present invention is defined by the appended claims and their legal equivalents.





BRIEF DESCRIPTION OF THE FIGURES

The invention may be more completely understood in connection with the following drawings, in which:



FIG. 1 is a schematic side view of a coating apparatus in accordance with various embodiments herein.



FIG. 2 is a schematic top view of a fluid applicator interfacing with a balloon catheter in accordance with various embodiments herein.



FIG. 3 is a schematic top view of a fluid applicator in accordance with various embodiments herein.



FIG. 4 is a schematic cross-sectional view of a fluid applicator in accordance with various embodiments herein.



FIG. 5 is a schematic side view is shown of a portion of a fluid applicator 202 in accordance with various embodiments herein.



FIG. 6 is a schematic cross-sectional view of a portion of a tip area of a fluid applicator as taken along line 6-6′ of FIG. 5 in accordance with various embodiments herein.



FIG. 7 is a schematic perspective view of a portion of a fluid applicator in accordance with various embodiments herein.



FIG. 8 is a schematic view of a fluid applicator in the process of depositing a coating onto a medical device in accordance with various embodiments herein.



FIG. 9 is a schematic perspective view of a coating being applied to a medical device surface in accordance with various embodiments herein.



FIG. 10 is a schematic view of a fluid applicator with a conical body in accordance with various embodiments herein.



FIG. 11 is a schematic view of a medical device in accordance with various embodiments herein.





While the invention is susceptible to various modifications and alternative forms, specifics thereof have been shown by way of example and drawings, and will be described in detail. It should be understood, however, that the invention is not limited to the particular embodiments described. On the contrary, the intention is to cover modifications, equivalents, and alternatives falling within the spirit and scope of the invention.


DETAILED DESCRIPTION OF THE INVENTION

Coatings are frequently applied onto the surfaces of various medical devices including, but not limited to, catheters and particularly balloon catheters. It is typically desirable for such coatings to be as uniform (in terms of thickness, composition, etc.) as possible. In some cases, the starting and/or stopping of a particular coating process (e.g., at the start of coating a particular device or when the coating for a particular device has been fully applied) can create challenges for forming a uniform coating. For example, during the coating process, a pool (or capillary pool) of coating materials may be associated with a direct-contact type coating applicator. This pool can help ensure desirable uniform coverage during the coating process. However, at the end of the process of coating a particular device, the coating applicator must be lifted from the surface of the medical device and some portion of the pool may be left behind on the surface. This can create an irregularity in the finished coating at the point where the coating tip is lifted from the surface unless additional processing steps are taken to remove it. In addition, this can result in the waste of materials in the coating solution, which may be extremely costly such as where the coating solution includes a costly active agent.


Embodiments herein can be used to apply uniform coatings, such as coatings including active agents, onto various medical devices, such as onto the balloons of drug coated or drug eluting balloon catheters, that have substantially uniform active agent concentrations along the length of the medical device. In addition, embodiments herein can minimize the amount of coating solution that is left on the medical device surface at the end of a coating cycle for enhanced coating uniformity and reduced waste. While not intending to be bound by theory, it is believed “double-bevel” or “double-face” coating applicators used with embodiments herein can enable the use of a smaller pool of coating materials during the coating process resulting in less excess material be left behind when the coating applicator is pulled up from the surface of the device being coated at the end of the coating cycle leading to enhanced coating uniformity and less coating solution waste.


Referring now to FIG. 1, a schematic side view is shown of a coating apparatus 100 in accordance with various embodiments herein. The coating apparatus 100 is shown in conjunction with a medical device 102 (which could be a drug coated balloon catheter). In this example, the medical device 102 can include a catheter shaft 104 and a balloon 106. The balloon 106 can assume a deflated configuration and an inflated configuration. The medical device 102 can include a distal end 103 and a proximal end 105. The medical device 102 can include a proximal end manifold (not shown). The coating apparatus 100 can include a coating application unit 108. The coating apparatus 100 can further include, in some embodiments, an axial motion mechanism 110 (axial with respect to the axis of rotation of the balloon catheter and thus parallel to the lengthwise axis of the balloon catheter) that can function to move one or more components of the coating application unit 108. In some embodiments, axial motion can be substantially horizontal. In other embodiments, axial motion can be substantially vertical. In some embodiments, axial motion can be somewhere in between horizontal and vertical, depending on the orientation of the lengthwise axis of the balloon catheter. However, it will be appreciated that in other embodiments, the coating application unit 108 can remain stationary.


Coating of the balloon 106 to make it drug coated can occur starting at the proximal end of the balloon and proceeding to the distal end. However, in other embodiments, coating of the balloon 106 can occur starting at the distal end of the balloon and proceeding to the proximal end. In many embodiments, coating can take place with a single pass of the coating application unit 108 with respect to the balloon. However, in other embodiments, multiple passes of the coating application unit with respect to the balloon can be made.


The coating apparatus 100 can further include a fluid pump 112. The fluid pump 112 can be, for example, a syringe pump. The fluid pump 112 can be in fluid communication with components of the coating application unit 108 (such as the fluid applicator) and with a fluid reservoir 114. The fluid pump 112 can operate to pump a coating solution at a rate sufficient to apply about 0.5 μl to about 10 μl of the coating solution per millimeter of length of the balloon or other device to be coated. The coating apparatus 100 can further include a rotation mechanism 116 (or rotating balloon catheter fixture). The rotation mechanism 116 can be directly or indirectly coupled to the drug coated balloon catheter in order to rotate the medical device 102 around its lengthwise (major) axis (about the central lumen of the catheter). In some embodiments, the drug coated balloon catheter can be rotated at a speed of between 100 and 400 rotations per minute. In some embodiments, the drug coated balloon catheter can be rotated at a speed of between 200 and 300 rotations per minute.


In some embodiments, a guide wire 107, passing through the central lumen of the catheter, can extend from the distal tip of the catheter and be inserted into a distal tip support ring 109 or guide. In this manner, the guide wire 107 can be used to support the distal tip of the balloon catheter to be coated while allowing the balloon catheter to rotate freely.


The coating apparatus 100 can further include, in some embodiments, an axial motion mechanism 118 which can be configured to move the medical device 102 in the direction of its lengthwise major axis. In some embodiments, axial motion can be substantially horizontal. In other embodiments, axial motion can be substantially vertical. In some embodiments, axial motion can be somewhere in between horizontal and vertical, depending on the orientation of the lengthwise axis of the balloon catheter. In some embodiments, the axial motion mechanism 118 can be a linear actuator. In some embodiments, the axial motion mechanism 118 can include an electric motor.


The coating apparatus 100 can further include a frame member 120 (in some embodiments this can also be referred to as an axial motion support rail). The frame member 120 can support other components of the coating apparatus 100 such as one or more guides 126. The frame member 120 can itself be support by a platform 122. The coating apparatus 100 can further include a controller 124 that can serve to control operation of the coating apparatus 100 including, specifically, fluid pump 112, axial motion mechanism 110, rotation mechanism 116, and axial motion mechanism 118. Further aspects of coating apparatus components are described in U.S. Pat. No. 10,099,041, the content of which is herein incorporated by reference.


In various embodiments, the coating application unit can move, relative to the catheter or balloon. For example, referring now to FIG. 2, a schematic top view is shown of a fluid applicator (which can be part of a coating application unit 108) interfacing with a balloon catheter (as merely one example of device that can be coated) in accordance with various embodiments herein. In this embodiment, it can be seen that the fluid applicator 202 moves in the direction of arrow 230 relative to the balloon 106 (or catheter shaft 104). It will be appreciated, however, that this movement is relative in the sense that in some embodiments the fluid applicator can move and the balloon can be stationary (or rotating, but stationary along its longitudinal axis), in some embodiments, the balloon can move (such as along its longitudinal axis) and the fluid applicator can be stationary, and in some embodiments both the balloon and the fluid applicator can move. The speed of movement of the device to be coated relative to the coating application unit can vary depending on the amount of coating solution to be applied. In some embodiments the speed can be from about 0.02 centimeters per second to about 0.2 centimeters per second.


It will be appreciated that based on the rotation of the drug coated balloon catheter and the movement of the balloon relative to the coating application unit that the path of the deposition of the coating onto the balloon follows a roughly helical path. It will be appreciated that the combination of the rotation speed of the drug coated balloon catheter and the speed of the movement of the balloon relative to the coating application unit can influence the amount of coating solution that is deposited at any given point and the nature of the helical path. For example, the coating material can be deposited in helical layers that partially overlap one another at their edges, helical layers wherein the edge of one turn substantially meets the edge of a previous turn, and helical layers wherein there are gaps in between subsequent helical turns. In some embodiments, these helical patterns can be configured so as to maximize release of the active agent. For example, in some embodiments, the apparatus can be used to coat device so as to produce helical ridges of the coating material on the balloon surface.


The fluid applicator 202 can be disposed at a particular angle (⊖1) with respect to the balloon 106 (or catheter shaft 104 or other medical device component). In some embodiments, ⊖1 can be from about 30 degrees to about 150 degrees, or about 45 degrees to about 135 degrees, or from about 60 degrees to about 120 degrees, or from about 75 degrees to about 105 degrees, or from about 85 degrees to about 95 degrees, or in some embodiments about 90 degrees.


Referring now to FIG. 3, a schematic top view is shown of a fluid applicator 202 in accordance with various embodiments herein. The fluid applicator 202 includes a tip area 302 and a shaft 304. The fluid applicator 202 can include a tip area 302 having a first face 306 (or beveled surface) that is angled with respect to the lengthwise axis of the fluid applicator 202. The first face 306 can extend all the way across the width of the fluid applicator 202 in some embodiments. In some embodiments, the first face 306 can have an angle ⊖2 with respect to a line parallel to the lengthwise axis of the fluid applicator 202. In some embodiments, angle ⊖2 can be from about 10 to about 80 degrees. In some embodiments, angle ⊖2 can be from about 25 to about 65 degrees. In some embodiments, angle ⊖2 can be from about 35 to about 55 degrees. In some embodiments, angle ⊖2 can be from about 40 to about 50 degrees. In some embodiments, angle ⊖2 can be about 45 degrees. The first face 306 can be referred to as a first bevel, such as in the context of reference to dual bevel fluid applicators and systems herein.


In some embodiments, the shaft 304 of the fluid applicator can be made of a material that flexes. For example, the shaft 304 can, in some embodiments, be sufficient flexible such that it can move in the Z-axis direction by about 0.5 to about 4 mm, or from about 1 to 2 mm. In some embodiments, the shaft 304 can be about 0.5 to 5 centimeters, or from about 1 to 2 centimeters in length or can span an equal distance before connecting to another structure that is part of the coating apparatus. Movement in the Z-axis direction (through flexing or movement enabled by a separate structure connected to the shaft such as a pivoting mount) can be significant for purposes of maintaining continuity of contact between the fluid applicator and the surface of the device to be coated. In some embodiments, the shaft 304 of the fluid applicator can be positioned such that it exerts a small degree of pressure against the surface of the medical device such that when an irregularity in the surface of the medical device is encountered the fluid applicator can move slightly in order to maintain contact with the balloon surface.


In some embodiments, the shaft 304 of the fluid applicator can be formed of a translucent or transparent material. In other embodiments, the shaft 304 can be substantially opaque.


Exemplary materials for the shaft 304 of the fluid applicator can include, but are not limited to, polymers such as ethylene vinyl acetate (EVA), fluoropolymers (such as PTFE and PVDF), polyamides, polycarbonate, polystyrene, polyolefins (such as polyethylene and polypropylene), polyketones, polyurethane, polyvinylchloride, and the like. Other materials beyond polymers can also be used including, but not limited to, metals, glasses, composites, and the like.


In various embodiments, the shaft 304 can be made from a tubing material of about 16 gauge to 22 gauge, or about 20 gauge, which corresponds to a wall thickness of about 0.035 inches (or 0.889 mm). In cross-section, the shaft 304 can be circular, oval, polygonal, or the like.


Referring now to FIG. 4, a schematic cross-sectional view is shown of a fluid applicator 202 in accordance with various embodiments herein. The fluid applicator defines a central channel 412 through which a fluid coating composition can flow before exiting the tip through an orifice 414 (or aperture) which can be at least partly within the first face 306. The diameter of the central channel 412 (or inner diameter of the shaft 304) can be from about 1000 microns to about 1000 microns, or from about 500 microns to about 200 microns.


In various embodiments herein, the fluid applicator 202 can include a tip area 302 that includes a second face (or additional contact surface or second bevel). Referring now to FIG. 5, a schematic side view is shown of a portion of a fluid applicator 202 in accordance with various embodiments herein. A second face 502 (or second contact surface or second bevel) can intersect the first face 306 at a bottom portion thereof. In some embodiments, the second face 502 is curved. In some embodiments, the second face 502 is concave. In some embodiments, the second face 502 can intersect the first face 306 at a sharp angle. In other embodiments, the second face 502 can intersect the first face 306 with a rounded transition between the two.


In some embodiments, the second face 502 intersects the first face at a position lower than half the total height of the first face 306. In some embodiments, the second face 502 slopes inward from the first face 306. In some embodiments, the second face 502 has a surface area that is less than 50% of the surface area of the first face 306 across the width of the fluid applicator. In some embodiments, the second face 502 has a length that is less than the length of the first face 306 across the width of the fluid applicator.


Referring now to FIG. 6, a cross-sectional view is shown of a portion of the tip area 302 of a fluid applicator 202 as taken along line 6-6′ of FIG. 5 showing the interface between the first face 306 or first bevel and the second face 502 or second bevel. The second face 502 or second bevel can intersect the first face 306 or first bevel at a particular angle ⊖3 that can from about 15 to about 90 degrees, or about 30 to about 85 degrees, or about 45 to about 85 degrees, or about 60 to about 85 degrees.


In some embodiments, the second face 502 can be substantially flat or planar. In other embodiments, the second face 502 can exhibit a degree of curvature. In some embodiments, the second face 502 can be concave. Referring now to FIG. 7, a schematic perspective view is shown of a portion of a fluid applicator 202 in accordance with various embodiments herein. In this view, it can be seen that the second face 502 follows a curve 702 that is concave with respect to the bottom of the first face 306. The specific radius of curvature can vary. In some embodiments, the radius of curvature can be equal to that of a sphere having an outer diameter of about 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, or 16 mm, or an amount falling within a range between any of the foregoing.


In some embodiments, the second face 502 can be aligned squarely with the first face 306. For example, where the second face 502 is curved, the direction of the apex of the curve can be aligned with arrow 704, or directly perpendicular to the first face 306. However, in some embodiments, the second face can be aligned differently. For example, in some embodiments, the second face can be aligned such that the direction of the apex of the curve can be aligned with arrow 706, or directly perpendicular to the shaft 304. In various embodiments, the second face can be aligned such that the direction of the apex of the curve is aligned in a direction between arrows 704 and 706.


The coating can be deposited in various ways using the fluid applicator. In some embodiments, the device-to-be-coated can rotate while the fluid application is in contact with a surface thereof and the coating solution can be pumped out of the fluid application. Referring now to FIG. 8, a schematic view is shown of a fluid applicator 202 in the process of depositing a coating 802 onto a balloon 106. The balloon 106 can rotate in the direction of arrow 804. The first face 306 can be disposed on the tip area 302 of the fluid applicator 202. A coating material solution can come out of the first face 306 and be deposited onto the surface of the balloon 106. The fluid applicator 202 can move in the direction of arrow 806 relative to the balloon 106.


In various embodiments herein, the “double-bevel” or “double-face” coating applicators used with embodiments herein can enable the use of a smaller pool of coating materials during the coating process resulting in less excess material being left behind when the coating tip is pulled up from the surface of the device being coated at the end of the coating cycle. This can lead to enhanced coating uniformity and less coating solution waste. Referring now to FIG. 9, a schematic perspective view is shown of a coating 802 being applied to a balloon 106 surface in accordance with various embodiments herein. A fluid coating solution 902 can pass out of an orifice 414 in the first face 306, wherein the first face 306 is disposed on the tip area 302 of the fluid applicator 202. A pool (or capillary pool) of coating solution 904 can be present in the area near where the tip area 302 interfaces with the balloon 106. The second face (not visible in this view) can enable the use of a smaller pool of coating solution 904 than may otherwise be present with an otherwise similar fluid applicator missing the second face.


While many solution applicators described herein have been shown with body members that are substantially uniform in diameter (such as a tubular shape), it will be appreciated that other shapes are also contemplated herein. By way of example, in some embodiments a fluid applicator with a conical shape can be used.


Referring now to FIG. 10, a schematic view is shown of a fluid applicator 202 with a shaft 304 that is conical in accordance with various embodiments herein. The shaft 304 can include a conical surface 1002. The fluid applicator 202 can include a tip area 302 including a first face 306 and a second face 502.


Medical Devices


It will be appreciated that many different medical devices can be coated using equipment and methods herein. In various embodiments, rotatable medical device can be coated using equipment and methods described herein. In various embodiments, relatively long medical devices (such as those having a length that it is at least 20 times their diameter) can be coated using equipment and methods described herein.


One type of medical device is a balloon catheter. Balloon catheter constructions are well known in the art and are described in various documents, for example, U.S. Pat. Nos. 4,195,637, 5,041,089, 5,087,246, 5,318,587, 5,382,234, 5,571,089, 5,776,101, 5,807,331, 5,882,336, 6,394,995, 6,517,515, 6,623,504, 6,896,842, and 7,163,523. Balloon catheters generally include four portions, the balloon, catheter shaft, guide wire, and manifold. A balloon catheter generally includes an elongated catheter shaft with an inflatable balloon attached to a distal section of the catheter shaft. At a proximal end of the catheter shaft, there is typically a manifold. At the manifold end, placement of the catheter can be facilitated using a guide wire. Guide wires are small and maneuverable when inserted into an artery. Once the guide wire is moved to the target location, the catheter with balloon portion is then fed over the guide wire until the balloon reaches the target location in the vessel. The balloon is typically inserted into the arterial lumen of a patient and advanced through the lumen in an unexpanded state. The balloon is then inflated when the catheter reaches target site resulting in application of mechanical force sufficient to cause vessel dilation. The balloon is typically inflated using a fluid, which is injected through an inflation port. The manifold can control the fluid introduction within shaft for expansion of the balloon. The mechanics of fluid transfer and introduction within balloons vary according to the specific design of the catheter, and are well known in the art.


Referring now to FIG. 11, a schematic view of a medical device 1100 is shown. The medical device 1100 can optionally include a connection manifold 1105, a shaft 1103 having a surface, and an expandable portion 1104 (such as a balloon) having a surface. The expandable portion 1104 can include a proximal end 1110 and a distal end 1112. Coating segments can be disposed onto one or more of the shaft 1103 and the expandable portion 1104. In some embodiments, the expandable portion 1104 can include multiple coating segments thereon disposed adjacently to one another.


Coating Solutions


It will be appreciated that coating solutions applied onto medical devices herein can include various components including, but not limited to, one or more active agents, carrier agents and/or solvents, polymers (including degradable or non-degradable polymers), cross-linking agents, excipients, and the like. The relative amounts of the components of the coating solution will depend on various factors including the desired amount of active agent to be applied to the balloon and the desired release rate of the active agent. Exemplary coating compositions are described in U.S. Publ. Pat. Appl. No. 2018/0110903, the content of which is herein incorporated by reference. Exemplary cross-linking agents are described in U.S. Pat. No. 8,889,760, the content of which is herein incorporated by reference.


In some embodiments, active agents can specifically include those wherein the coating solution is the form of a suspension or emulsion including active agent particles.


Methods


In various embodiments, a method of coating a medical device is included. The method can include rotating a medical device to be coated with a rotation mechanism. Rotation can be performed at various speeds such as 20, 50, 100, 150, 200, 300, 400, 500, 600, 800 or 1000 RPM or more, or a speed falling within a range between any of the foregoing. The method can include contacting the surface of the medical device with a fluid applicator having a lengthwise axis and a width. The fluid applicator can have a tip, the tip comprising a first face across the width of the fluid applicator. The first face can be oriented at an angle of from about 15 to about 75 degrees with respect to the lengthwise axis of the fluid applicator, wherein the fluid applicator defines a second face intersecting the first face. The method can include applying a coating solution onto the surface of the balloon with the fluid applicator. In some embodiments, the second face is curved. In some embodiments, the second face is concave. In some embodiments, the second face intersects the first face at an angle of about 15 to 75 degrees. In some embodiments, the second face intersects the first face at a position lower than half the total height of the first face. In some embodiments, the fluid applicator can include a polymeric tube defining a central channel for passage of a fluid therethrough. In some embodiments, the fluid applicator can be in fluid communication with a fluid supply pump. In some embodiments, the second face slopes inward from the first face. In some embodiments, the second face has a surface area that is less than 50% of the surface area of the first face across the width of the fluid applicator. In some embodiments, the second face has a length that is less than the length of the first face across the width of the fluid applicator.


The embodiments of the present invention described herein are not intended to be exhaustive or to limit the invention to the precise forms disclosed in the following detailed description. Rather, the embodiments are chosen and described so that others skilled in the art can appreciate and understand the principles and practices of the present invention.


All publications and patents mentioned herein are hereby incorporated by reference. The publications and patents disclosed herein are provided solely for their disclosure. Nothing herein is to be construed as an admission that the inventors are not entitled to antedate any publication and/or patent, including any publication and/or patent cited herein.


It should be noted that, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to a composition containing “a compound” includes a mixture of two or more compounds. It should also be noted that the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.


It should also be noted that, as used in this specification and the appended claims, the phrase “configured” describes a system, apparatus, or other structure that is constructed or configured to perform a particular task or adopt a particular configuration to. The phrase “configured” can be used interchangeably with other similar phrases such as arranged and configured, constructed and arranged, constructed, manufactured and arranged, and the like.


All publications and patent applications in this specification are indicative of the level of ordinary skill in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated by reference.


The invention has been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope of the invention.

Claims
  • 1. A coating apparatus comprising: a coating application unit comprising a fluid applicator having a lengthwise axis and a width, the fluid applicator comprising a tip, the tip comprising a first face across the width of the fluid applicator, the first face oriented at an angle of from about 15 to about 75 degrees with respect to the lengthwise axis of the fluid applicator,wherein the fluid applicator defines a second face intersecting the first face, wherein the second face is configured to contact a surface of a device to be coated while the fluid applicator applies a coating to the device, wherein the second face is curved and concave;a rotation mechanism; andan axial motion mechanism, the axial motion mechanism configured to cause movement of at least one of the coating application unit and the rotation mechanism with respect to one another.
  • 2. The coating apparatus of claim 1, wherein the second face intersects the first face at an angle of about 15 to 90 degrees.
  • 3. The coating apparatus of claim 1, wherein the second face intersects the first face at a position lower than half the total height of the first face.
  • 4. The coating apparatus of claim 1, the fluid applicator comprising a polymeric tube defining a central channel for passage of a fluid therethrough.
  • 5. The coating apparatus of claim 1, the fluid applicator in fluid communication with a fluid supply pump.
  • 6. The coating apparatus of claim 1, wherein the second face slopes inward from the first face.
  • 7. The coating apparatus of claim 1, wherein the second face has a surface area that is less than 50% of the surface area of the first face across the width of the fluid applicator.
  • 8. The coating apparatus of claim 1, wherein the second face has a length that is less than the length of the first face across the width of the fluid applicator.
  • 9. A coating apparatus comprising: a coating application unit comprising a fluid applicator having a lengthwise axis and a width, the fluid applicator comprising a tip, the tip comprising a first face across the width of the fluid applicator, the first face oriented at an angle of from about 15 to about 75 degrees with respect to the lengthwise axis of the fluid applicator,wherein the fluid applicator defines a second face intersecting the first face, wherein the second face is oriented at an oblique angle relative to the lengthwise axis of the fluid applicator, wherein the second face is configured to contact a surface of a device to be coated while the fluid applicator applies a coating to the device, wherein the second face is concave;a rotation mechanism configured to rotate the device about a rotation axis; andan axial motion mechanism, the axial motion mechanism configured to cause movement of at least one of the coating application unit and the rotation mechanism with respect to one another about an axis parallel to the rotation axis.
  • 10. A coating apparatus comprising: a coating application unit comprising a fluid applicator having a lengthwise axis and a width, the fluid applicator comprising a tip, the tip comprising a first face across the width of the fluid applicator, the first face oriented at an angle of from about 15 to about 75 degrees with respect to the lengthwise axis of the fluid applicator,wherein the fluid applicator defines a second face intersecting the first face, wherein the second face is configured to contact a surface of a device to be coated while the fluid applicator applies a coating to the device, a rotation mechanism configured to rotate a device about a rotation axis that is substantially orthogonal to the lengthwise axis of the fluid applicator, wherein the second face is concave; andan axial motion mechanism, the axial motion mechanism configured to cause movement of at least one of the coating application unit and the rotation mechanism with respect to one another.
  • 11. The coating apparatus of claim 10, wherein the rotation mechanism is configured to rotate the part about a lengthwise axis of the part.
  • 12. The coating apparatus of claim 10, wherein the fluid applicator is configured to remain stationary.
  • 13. The coating apparatus of claim 10, wherein the fluid applicator is configured to contact a surface of the part.
  • 14. The coating apparatus of claim 10, wherein the part is a balloon catheter.
Parent Case Info

This application claims the benefit of U.S. Provisional Application No. 62/772,673, filed Nov. 29, 2018, the content of which is herein incorporated by reference in its entirety.

US Referenced Citations (568)
Number Name Date Kind
273410 Wadleigh et al. Mar 1883 A
554114 Evertz Feb 1896 A
1281672 Schorn Oct 1918 A
1866100 Hach Jul 1932 A
2253019 Crepeau Aug 1941 A
2329438 Fiedler Sep 1943 A
2330880 Gladfelter et al. Oct 1943 A
2335116 Hansen Nov 1943 A
2398506 Rogers Apr 1946 A
2493787 Torretti Jan 1950 A
2781280 Miller Feb 1957 A
2821158 Brown et al. Jan 1958 A
2881461 Parker Apr 1959 A
3198170 Toshio Aug 1965 A
3318281 Plegat May 1967 A
3348964 Good et al. Oct 1967 A
3416530 Ness Dec 1968 A
3502494 Ishiwata et al. Mar 1970 A
3625214 Higuchi Dec 1971 A
3645773 Herzhoff et al. Feb 1972 A
3663292 Herzhoff et al. May 1972 A
3669917 Ando et al. Jun 1972 A
3699917 Deverse et al. Oct 1972 A
3702739 Rentfrow Nov 1972 A
3723120 Hummel et al. Mar 1973 A
3736199 Mason May 1973 A
3837805 Boucher Sep 1974 A
3935896 Tegtmeier et al. Feb 1976 A
3936549 Kohler et al. Feb 1976 A
3963069 Marti et al. Jun 1976 A
3966120 Furgalus et al. Jun 1976 A
4000745 Goldberg Jan 1977 A
4016306 Miyagawa et al. Apr 1977 A
4051805 Waldrum Oct 1977 A
4060116 Frailly Nov 1977 A
4069307 Higuchi et al. Jan 1978 A
4073335 Fort et al. Feb 1978 A
4075975 Oswald Feb 1978 A
4082870 Yenni Apr 1978 A
4144317 Higuchi et al. Mar 1979 A
4146036 Dutcher et al. Mar 1979 A
4148934 Baker Apr 1979 A
4153201 Berger et al. May 1979 A
4174678 Van Den Bergh Nov 1979 A
4195637 Gruntzig et al. Apr 1980 A
4196231 Hubers Apr 1980 A
4197338 Perna Apr 1980 A
4206756 Grossan Jun 1980 A
4209019 Dutcher et al. Jun 1980 A
4240373 Anger Dec 1980 A
4257343 Kullander Mar 1981 A
4289089 Tacke et al. Sep 1981 A
4292965 Nash Oct 1981 A
4300557 Refojo et al. Nov 1981 A
4301968 Berger et al. Nov 1981 A
4304765 Shell et al. Dec 1981 A
4337896 Berger et al. Jul 1982 A
4352459 Berger et al. Oct 1982 A
4364879 Gut et al. Dec 1982 A
4375820 Vinarcsik et al. Mar 1983 A
4415654 Pohl Nov 1983 A
4475972 Wong Oct 1984 A
4503802 Keller et al. Mar 1985 A
4541564 Berger et al. Sep 1985 A
4544626 Sullivan Oct 1985 A
4567934 Nakao et al. Feb 1986 A
4572451 Ikeda et al. Feb 1986 A
4575330 Hull Mar 1986 A
4603058 Adams Jul 1986 A
4616593 Kawamura et al. Oct 1986 A
4622917 Schramm Nov 1986 A
4638045 Kohn et al. Jan 1987 A
4655393 Berger Apr 1987 A
4678466 Rosenwald Jul 1987 A
4723708 Berger et al. Feb 1988 A
4743252 Martin, Jr. et al. May 1988 A
4764377 Goodson Aug 1988 A
4819661 Heil et al. Apr 1989 A
4824017 Mansfield Apr 1989 A
4853224 Wong Aug 1989 A
4863457 Lee et al. Sep 1989 A
4892736 Goodson Jan 1990 A
4927741 Garth et al. May 1990 A
4953564 Berthlelsen Sep 1990 A
4959217 Sanders et al. Sep 1990 A
4971895 Sullivan Nov 1990 A
4972848 Di Domenico et al. Nov 1990 A
4978067 Berger et al. Dec 1990 A
4988883 Oppawsky Jan 1991 A
4997652 Wong et al. Mar 1991 A
5002067 Berthelsen et al. Mar 1991 A
5002582 Guire et al. Mar 1991 A
5003992 Holleman et al. Apr 1991 A
5036634 Lessard et al. Aug 1991 A
5041089 Mueller et al. Aug 1991 A
5049404 Kisler et al. Sep 1991 A
5069940 Wenrick Dec 1991 A
5071337 Heller et al. Dec 1991 A
5076285 Hess et al. Dec 1991 A
5076974 Modrek et al. Dec 1991 A
5087246 Smith Feb 1992 A
5090084 De Feb 1992 A
5098443 Parel et al. Mar 1992 A
5102402 Dror et al. Apr 1992 A
5114719 Sabel et al. May 1992 A
5120312 Wigness et al. Jun 1992 A
5164188 Wong Nov 1992 A
5183509 Brown et al. Feb 1993 A
5207343 Bogadi May 1993 A
5219120 Ehrenberg et al. Jun 1993 A
5219690 Hammond Jun 1993 A
5221698 Amiden et al. Jun 1993 A
5229128 Haddad et al. Jul 1993 A
5246867 Maliwal et al. Sep 1993 A
5248752 Argyropoulos et al. Sep 1993 A
5254164 Masahumi Oct 1993 A
5255693 Dutcher et al. Oct 1993 A
5300108 Rebell et al. Apr 1994 A
5300114 Gwon Apr 1994 A
5304121 Sahatjian Apr 1994 A
5310559 Shah et al. May 1994 A
5314419 Pelling et al. May 1994 A
5318587 Davey Jun 1994 A
5324325 Moaddeb Jun 1994 A
5344298 Hull Sep 1994 A
5364343 Apolet et al. Nov 1994 A
5372577 Ungerleider Dec 1994 A
5378475 Smith et al. Jan 1995 A
5382234 Cornelius et al. Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5387247 Vallana et al. Feb 1995 A
5395618 Darougar et al. Mar 1995 A
5405376 Mulier et al. Apr 1995 A
5405631 Rosenthal Apr 1995 A
5410773 Forkner May 1995 A
5413638 Bernstein, Jr. et al. May 1995 A
5414075 Swan et al. May 1995 A
5421979 Stevenson Jun 1995 A
5423777 Tajiri et al. Jun 1995 A
5431649 Mulier et al. Jul 1995 A
5437656 Shikani et al. Aug 1995 A
5443505 Wong et al. Aug 1995 A
5447724 Helmus et al. Sep 1995 A
5449382 Dayton Sep 1995 A
5464650 Berg et al. Nov 1995 A
5466233 Weiner et al. Nov 1995 A
5472436 Fremstad Dec 1995 A
5476511 Gwon et al. Dec 1995 A
5501735 Pender Mar 1996 A
5501856 Ohtori et al. Mar 1996 A
5512055 Domb et al. Apr 1996 A
5525348 Whitbourne et al. Jun 1996 A
5527389 Rosenblum et al. Jun 1996 A
5545208 Wolff et al. Aug 1996 A
5556633 Haddad et al. Sep 1996 A
5571089 Crocker Nov 1996 A
5578075 Dayton Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5591227 Dinh et al. Jan 1997 A
5605696 Eury et al. Feb 1997 A
5609629 Fearnot et al. Mar 1997 A
5618568 Seckora et al. Apr 1997 A
5624411 Tuch Apr 1997 A
5624975 Valencia Apr 1997 A
5626919 Chapman et al. May 1997 A
5630879 Eichmann et al. May 1997 A
5637113 Tartaglia et al. Jun 1997 A
5637460 Swan et al. Jun 1997 A
5643362 Garves Jul 1997 A
5645592 Nicolais et al. Jul 1997 A
5651986 Brem Jul 1997 A
5656332 Saito et al. Aug 1997 A
5658387 Reardon et al. Aug 1997 A
5673473 Johnson et al. Oct 1997 A
5679400 Tuch Oct 1997 A
5714360 Swan et al. Feb 1998 A
5725493 Avery et al. Mar 1998 A
5743964 Pankake Apr 1998 A
5766242 Wong et al. Jun 1998 A
5773019 Ashton et al. Jun 1998 A
5776101 Goy Jul 1998 A
5788772 Kunieda et al. Aug 1998 A
5807331 Den Heijer et al. Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810836 Hussein et al. Sep 1998 A
5824072 Wong Oct 1998 A
5830173 Avery et al. Nov 1998 A
5833715 Vachon et al. Nov 1998 A
5833891 Subramaniam et al. Nov 1998 A
5837008 Berg et al. Nov 1998 A
5837088 Palmgren et al. Nov 1998 A
5837313 Ding et al. Nov 1998 A
5849359 Burns et al. Dec 1998 A
5858435 Gallo Jan 1999 A
5868697 Richter et al. Feb 1999 A
5877224 Brocchini et al. Mar 1999 A
5882336 Janacek Mar 1999 A
5882405 Kish et al. Mar 1999 A
5886026 Hunter et al. Mar 1999 A
5897911 Loeffler Apr 1999 A
5904144 Hammage et al. May 1999 A
5913653 Kempf Jun 1999 A
5921982 Lesh et al. Jul 1999 A
5925885 Clark et al. Jul 1999 A
5928662 Phillips Jul 1999 A
5972027 Johnson Oct 1999 A
5972369 Roorda et al. Oct 1999 A
5976256 Kawano Nov 1999 A
5980972 Ding Nov 1999 A
5989579 Darougar et al. Nov 1999 A
5992568 Craig et al. Nov 1999 A
5997517 Whitbourne Dec 1999 A
6001386 Ashton et al. Dec 1999 A
6001425 Stash et al. Dec 1999 A
6019784 Hines Feb 2000 A
6033582 Lee et al. Mar 2000 A
6053924 Hussein Apr 2000 A
6056998 Fujimoto May 2000 A
6070697 Millard Jun 2000 A
6074661 Olejnik et al. Jun 2000 A
6091978 Johnson et al. Jul 2000 A
6094887 Swank et al. Aug 2000 A
6096070 Ragheb et al. Aug 2000 A
6099562 Ding et al. Aug 2000 A
6102887 Altman Aug 2000 A
6110483 Whitbourne et al. Aug 2000 A
6117456 Lee et al. Sep 2000 A
6120536 Ding et al. Sep 2000 A
6129933 Oshlack et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6153252 Hossainy et al. Nov 2000 A
6156373 Zhong et al. Dec 2000 A
6156526 Newman Dec 2000 A
6165526 Newman et al. Dec 2000 A
6177095 Sawhney et al. Jan 2001 B1
6187370 Dinh et al. Feb 2001 B1
6190077 Newson et al. Feb 2001 B1
6197324 Crittenden Mar 2001 B1
6203551 Wu Mar 2001 B1
6203556 Evans et al. Mar 2001 B1
6203732 Clubb et al. Mar 2001 B1
6207337 Swain Mar 2001 B1
6212434 Scheiner et al. Apr 2001 B1
6214008 Illi Apr 2001 B1
6214115 Taylor et al. Apr 2001 B1
6214901 Chudzik et al. Apr 2001 B1
6217895 Guo et al. Apr 2001 B1
6218016 Tedeschi Apr 2001 B1
6245089 Daniel et al. Jun 2001 B1
6245099 Edwin et al. Jun 2001 B1
6248112 Gambale et al. Jun 2001 B1
6251090 Avery et al. Jun 2001 B1
6251136 Guruwaiya et al. Jun 2001 B1
6251418 Ahern et al. Jun 2001 B1
6254921 Chappa et al. Jul 2001 B1
6278018 Swan Aug 2001 B1
6279505 Plester et al. Aug 2001 B1
6287285 Michal et al. Sep 2001 B1
6290728 Phelps et al. Sep 2001 B1
6298272 Peterfeso et al. Oct 2001 B1
6303148 Hennink et al. Oct 2001 B1
6306125 Parker et al. Oct 2001 B1
6306426 Olejnik et al. Oct 2001 B1
6309370 Haim et al. Oct 2001 B1
6322847 Zhong et al. Nov 2001 B1
RE37463 Altman Dec 2001 E
6331313 Wong et al. Dec 2001 B1
6333595 Horikawa et al. Dec 2001 B1
6344035 Chudzik et al. Feb 2002 B1
6345630 Fishkin et al. Feb 2002 B2
6358247 Altman et al. Mar 2002 B1
6358556 Ding et al. Mar 2002 B1
6360129 Ley et al. Mar 2002 B1
6368658 Schwarz et al. Apr 2002 B1
6375972 Guo et al. Apr 2002 B1
6394995 Solar et al. May 2002 B1
6395326 Castro et al. May 2002 B1
6399144 Dinh et al. Jun 2002 B2
6399655 De et al. Jun 2002 B1
6399704 Laurin et al. Jun 2002 B1
6406754 Chappa et al. Jun 2002 B2
6431770 Kurematsu et al. Aug 2002 B1
6435959 Skrmetta Aug 2002 B1
6451373 Hossainy et al. Sep 2002 B1
6478776 Roseman et al. Nov 2002 B1
6497691 Bevins et al. Dec 2002 B1
6501994 Janke et al. Dec 2002 B1
6505082 Scheiner et al. Jan 2003 B1
6506411 Hunter et al. Jan 2003 B2
6506437 Harish et al. Jan 2003 B1
6517515 Eidenschink Feb 2003 B1
6517889 Jayaraman Feb 2003 B1
6521299 Dessauer Feb 2003 B1
6527863 Pacetti et al. Mar 2003 B1
6544544 Hunter et al. Apr 2003 B2
6544582 Yoe Apr 2003 B1
6547787 Altman et al. Apr 2003 B1
6548078 Guo et al. Apr 2003 B2
6555157 Hossainy Apr 2003 B1
6559560 Jin et al. May 2003 B1
6562051 Bolduc et al. May 2003 B1
6562136 Chappa et al. May 2003 B1
6565659 Pacetti et al. May 2003 B1
6572644 Moein Jun 2003 B1
6585764 Wright et al. Jul 2003 B2
6595958 Mickley Jul 2003 B1
6599560 Daggett et al. Jul 2003 B1
6605154 Villareal Aug 2003 B1
6607598 Schwarz et al. Aug 2003 B2
6613017 Mickley Sep 2003 B1
6616765 Castro et al. Sep 2003 B1
6623504 Vrba et al. Sep 2003 B2
6653426 Alvarado et al. Nov 2003 B2
6656529 Pankake Dec 2003 B1
6669980 Hansen Dec 2003 B2
6669994 Swan et al. Dec 2003 B2
6673154 Pacetti et al. Jan 2004 B1
6676987 Zhong et al. Jan 2004 B2
6695920 Pacetti et al. Feb 2004 B1
6706023 Huttner et al. Mar 2004 B1
6709514 Hossainy Mar 2004 B1
6709712 Chappa et al. Mar 2004 B2
6713081 Robinson et al. Mar 2004 B2
6716081 Kim et al. Apr 2004 B2
6716196 Lesh et al. Apr 2004 B2
6719750 Varner et al. Apr 2004 B2
6719805 Ahern Apr 2004 B1
6723373 Narayanan et al. Apr 2004 B1
6725901 Kramer et al. Apr 2004 B1
6726918 Wong et al. Apr 2004 B1
6743233 Baldwin et al. Jun 2004 B1
6743462 Pacetti Jun 2004 B1
6743463 Weber et al. Jun 2004 B2
6752959 Smith et al. Jun 2004 B2
6764470 Dimick Jul 2004 B2
6783793 Hossainy et al. Aug 2004 B1
6803070 Weber Oct 2004 B2
6818063 Kerrigan Nov 2004 B1
6896842 Hamilton et al. May 2005 B1
6941632 Mead et al. Sep 2005 B1
6981982 Armstrong et al. Jan 2006 B2
7010933 Ishitomi et al. Mar 2006 B2
7041174 Carlson et al. May 2006 B2
7045015 Renn et al. May 2006 B2
7077848 De Juan, Jr. et al. Jul 2006 B1
7077910 Chappa et al. Jul 2006 B2
7087658 Swan et al. Aug 2006 B2
7090421 Mead et al. Aug 2006 B1
7105350 Foster et al. Sep 2006 B2
7125577 Chappa Oct 2006 B2
7163523 Devens, Jr. et al. Jan 2007 B2
7186374 Zelina et al. Mar 2007 B2
7192484 Chappa et al. Mar 2007 B2
7198675 Fox et al. Apr 2007 B2
7335314 Wu Feb 2008 B2
7563324 Chen et al. Jul 2009 B1
7611532 Bates et al. Nov 2009 B2
7638156 Kokish et al. Dec 2009 B1
7669548 Chappa Mar 2010 B2
7743727 Shekalim Jun 2010 B2
7806612 Wangler Oct 2010 B1
7883749 Carlson Feb 2011 B2
7958840 Chappa Jun 2011 B2
8003156 Van Sciver Aug 2011 B2
8166909 Chappa May 2012 B2
8171595 Umhoefer, Jr. et al. May 2012 B1
8246974 Chappa Aug 2012 B2
8282981 Andreacchi et al. Oct 2012 B2
8318263 Carlson et al. Nov 2012 B2
D676975 Bickford Feb 2013 S
8632837 Gong et al. Jan 2014 B2
8844543 Bickford et al. Sep 2014 B2
8889760 Kurdyumov et al. Nov 2014 B2
8961054 Gilbert et al. Feb 2015 B2
8974134 Wilson et al. Mar 2015 B2
9205447 Wilson Dec 2015 B2
9283350 Chappa et al. Mar 2016 B2
9308355 Chappa et al. Apr 2016 B2
9364349 Chappa et al. Jun 2016 B2
9623215 Chappa et al. Apr 2017 B2
9827401 Chappa Nov 2017 B2
10099041 Chappa et al. Oct 2018 B2
10507309 Chappa et al. Dec 2019 B2
20010001824 Wu May 2001 A1
20010014717 Hossainy et al. Aug 2001 A1
20010022988 Schwarz et al. Sep 2001 A1
20010026834 Chappa et al. Oct 2001 A1
20010029351 Falotico et al. Oct 2001 A1
20020005206 Falotico et al. Jan 2002 A1
20020007213 Falotico et al. Jan 2002 A1
20020007214 Falotico Jan 2002 A1
20020007215 Falotico et al. Jan 2002 A1
20020013298 Hunter Jan 2002 A1
20020018795 Whitbourne et al. Feb 2002 A1
20020026176 Varner et al. Feb 2002 A1
20020026236 Helmus et al. Feb 2002 A1
20020032434 Chudzik et al. Mar 2002 A1
20020032477 Helmus et al. Mar 2002 A1
20020046521 Steinacker, Sr. et al. Apr 2002 A1
20020051730 Bodnar et al. May 2002 A1
20020054900 Kamath et al. May 2002 A1
20020062730 Thornton May 2002 A1
20020082679 Sirhan et al. Jun 2002 A1
20020091433 Ding et al. Jul 2002 A1
20020094440 Llanos et al. Jul 2002 A1
20020103526 Steinke Aug 2002 A1
20020107330 Pinchuk et al. Aug 2002 A1
20020111590 Davila et al. Aug 2002 A1
20020114823 Sirhan et al. Aug 2002 A1
20020115400 Skrmetta Aug 2002 A1
20020120326 Michal Aug 2002 A1
20020133183 Lentz et al. Sep 2002 A1
20020138048 Tuch Sep 2002 A1
20020155212 Hossainy Oct 2002 A1
20020159915 Zelina et al. Oct 2002 A1
20020165265 Hunter et al. Nov 2002 A1
20020168394 Hossainy et al. Nov 2002 A1
20020188037 Chudzik et al. Dec 2002 A1
20020188170 Santamore et al. Dec 2002 A1
20020198511 Varner et al. Dec 2002 A1
20030003221 Zhong et al. Jan 2003 A1
20030004209 Hunter et al. Jan 2003 A1
20030014036 Varner et al. Jan 2003 A1
20030021828 Guo et al. Jan 2003 A1
20030031780 Chudzik et al. Feb 2003 A1
20030039689 Chen et al. Feb 2003 A1
20030044514 Richard Mar 2003 A1
20030054023 Hughes et al. Mar 2003 A1
20030054090 Hansen Mar 2003 A1
20030059520 Chen et al. Mar 2003 A1
20030059920 Drohan et al. Mar 2003 A1
20030060783 Koole et al. Mar 2003 A1
20030065332 Tenhuisen et al. Apr 2003 A1
20030083646 Sirhan et al. May 2003 A1
20030088307 Shulze et al. May 2003 A1
20030094736 Qin et al. May 2003 A1
20030096131 Beavers May 2003 A1
20030113439 Pacetti et al. Jun 2003 A1
20030120200 Bergheim et al. Jun 2003 A1
20030143315 Pui et al. Jul 2003 A1
20030150380 Yoe Aug 2003 A1
20030152693 Su et al. Aug 2003 A1
20030157187 Hunter Aug 2003 A1
20030157241 Hossainy et al. Aug 2003 A1
20030158598 Ashton et al. Aug 2003 A1
20030161937 Leiby et al. Aug 2003 A1
20030165613 Chappa et al. Sep 2003 A1
20030175324 Robinson et al. Sep 2003 A1
20030181848 Bergheim et al. Sep 2003 A1
20030190420 Chappa et al. Oct 2003 A1
20030207856 Tremble et al. Nov 2003 A1
20030215564 Heller et al. Nov 2003 A1
20030229333 Ashton et al. Dec 2003 A1
20030232087 Lawin et al. Dec 2003 A1
20030232122 Chappa et al. Dec 2003 A1
20030236513 Schwarz et al. Dec 2003 A1
20030236514 Schwarz Dec 2003 A1
20040006146 Evans et al. Jan 2004 A1
20040022853 Ashton et al. Feb 2004 A1
20040034357 Beane et al. Feb 2004 A1
20040037886 Hsu Feb 2004 A1
20040044404 Stucke et al. Mar 2004 A1
20040047911 Lyu et al. Mar 2004 A1
20040062592 Shekalim et al. Apr 2004 A1
20040062875 Chappa et al. Apr 2004 A1
20040073298 Hossainy Apr 2004 A1
20040081745 Hansen Apr 2004 A1
20040111818 Ma Jun 2004 A1
20040121014 Guo et al. Jun 2004 A1
20040133155 Varner et al. Jul 2004 A1
20040137059 Nivaggioli et al. Jul 2004 A1
20040142013 Rubsamen Jul 2004 A1
20040143314 Sommer et al. Jul 2004 A1
20040161547 Carlson et al. Aug 2004 A1
20040185168 Weber et al. Sep 2004 A1
20040194704 Chappa et al. Oct 2004 A1
20040211362 Castro et al. Oct 2004 A1
20040213893 Boulais Oct 2004 A1
20050015142 Austin et al. Jan 2005 A1
20050019371 Anderson et al. Jan 2005 A1
20050059956 Varner et al. Mar 2005 A1
20050098097 Chen et al. May 2005 A1
20050129732 Rubsamen Jun 2005 A1
20050142070 Hartley Jun 2005 A1
20050143363 De Juan et al. Jun 2005 A1
20050147690 Masters et al. Jul 2005 A1
20050158449 Chappa Jul 2005 A1
20050196518 Stenzel et al. Sep 2005 A1
20050233061 Schwarz et al. Oct 2005 A1
20050233062 Hossainy et al. Oct 2005 A1
20050240147 Makower et al. Oct 2005 A1
20050255142 Chudzik et al. Nov 2005 A1
20050271703 Anderson et al. Dec 2005 A1
20050271706 Anderson et al. Dec 2005 A1
20050276837 Anderson et al. Dec 2005 A1
20050281863 Anderson et al. Dec 2005 A1
20050287188 Anderson et al. Dec 2005 A1
20060020295 Brockway et al. Jan 2006 A1
20060029720 Panos et al. Feb 2006 A1
20060045981 Tsushi et al. Mar 2006 A1
20060059520 Miyazawa et al. Mar 2006 A1
20060064134 Mazar et al. Mar 2006 A1
20060064142 Chavan et al. Mar 2006 A1
20060074404 Struble Apr 2006 A1
20060088653 Chappa Apr 2006 A1
20060096535 Haller et al. May 2006 A1
20060110428 De Juan et al. May 2006 A1
20060111754 Rezai et al. May 2006 A1
20060116590 Fayram et al. Jun 2006 A1
20060165872 Chappa et al. Jul 2006 A1
20060191476 Nagase et al. Aug 2006 A1
20060269663 Mori et al. Nov 2006 A1
20070065481 Chudzik et al. Mar 2007 A1
20070101933 Chappa May 2007 A1
20070116855 Fox et al. May 2007 A1
20070131165 Fox et al. Jun 2007 A1
20070141232 Tochterman et al. Jun 2007 A1
20070259100 Guerriero et al. Nov 2007 A1
20070259102 Mcniven et al. Nov 2007 A1
20070259125 O'brien et al. Nov 2007 A1
20070275175 Hossainy Nov 2007 A1
20080149025 Swenson Jun 2008 A1
20080179781 Iwata Jul 2008 A1
20080274266 Davis et al. Nov 2008 A1
20090018643 Hashi et al. Jan 2009 A1
20090054837 Von Holst et al. Feb 2009 A1
20090084311 Yoshida et al. Apr 2009 A1
20090090299 Menendez et al. Apr 2009 A1
20090176030 Carlson et al. Jul 2009 A1
20090269481 Chappa et al. Oct 2009 A1
20090317537 Andreacchi Dec 2009 A1
20100040766 Chappa et al. Feb 2010 A1
20100055294 Wang et al. Mar 2010 A1
20100070020 Hashi et al. Mar 2010 A1
20100179475 Hoffmann et al. Jul 2010 A1
20100227044 Scheer Sep 2010 A1
20100272774 Chappa Oct 2010 A1
20100319183 Hulseman et al. Dec 2010 A1
20110046724 Heilmann et al. Feb 2011 A1
20110104392 Carlson et al. May 2011 A1
20110151199 Nelson et al. Jun 2011 A1
20110238011 Scheller et al. Sep 2011 A1
20110253170 Clark et al. Oct 2011 A1
20110281019 Gong et al. Nov 2011 A1
20110281020 Gong et al. Nov 2011 A1
20110311713 O'neill et al. Dec 2011 A1
20110311764 Hulseman et al. Dec 2011 A1
20120025145 Tokumoto Feb 2012 A1
20120043693 King et al. Feb 2012 A1
20120059317 Michiyo et al. Mar 2012 A1
20120100279 Neumann et al. Apr 2012 A1
20120258246 Saine et al. Oct 2012 A1
20120315376 Nguyen et al. Dec 2012 A1
20130337147 Chappa et al. Dec 2013 A1
20140121597 Chappa et al. May 2014 A1
20140161964 Chappa et al. Jun 2014 A1
20140328998 Chappa et al. Nov 2014 A1
20150017429 Li et al. Jan 2015 A1
20150044376 Topf et al. Feb 2015 A1
20160256668 Chappa et al. Sep 2016 A1
20160271644 Weinmann et al. Sep 2016 A1
20180036519 Chappa et al. Feb 2018 A1
20180110903 Slager et al. Apr 2018 A1
20190099778 Antoniazzi Apr 2019 A1
20190143661 Hunt et al. May 2019 A1
20190151629 Chappa et al. May 2019 A1
20200353502 Ko Nov 2020 A1
20200360572 Militello et al. Nov 2020 A1
Foreign Referenced Citations (92)
Number Date Country
2351016 Dec 2001 CA
3335502 Mar 1985 DE
20200223 Apr 2002 DE
10053826 May 2002 DE
0096433 Dec 1983 EP
0144873 Jun 1985 EP
0414233 Feb 1991 EP
0604022 Jun 1994 EP
0623354 Nov 1994 EP
0716836 Jun 1996 EP
0734721 Oct 1996 EP
0747069 Dec 1996 EP
0857516 Feb 1998 EP
0832655 Apr 1998 EP
0834282 Apr 1998 EP
0945148 Sep 1999 EP
0879595 Jan 2003 EP
1374924 Jan 2004 EP
1382302 Jan 2004 EP
1594623 Apr 2007 EP
0923953 Aug 2008 EP
1610836 Aug 2008 EP
2994241 Mar 2016 EP
3549679 Oct 2019 EP
1304457 Aug 1962 FR
2733163 Oct 1996 FR
525373 Aug 1940 GB
757659 Sep 1956 GB
2301296 Dec 1996 GB
104464 Apr 2001 GB
57048354 Mar 1982 JP
63-011547 Jan 1988 JP
02-036882 Feb 1990 JP
H0262550 Mar 1990 JP
H03021367 Jan 1991 JP
09-038546 Feb 1997 JP
09-194347 Jul 1997 JP
2003039015 Feb 2003 JP
2005059225 Mar 2005 JP
06-246207 Sep 2006 JP
08-086466 Apr 2008 JP
2015527092 Sep 2015 JP
2016504058 Feb 2016 JP
6445532 Dec 2018 JP
1989005664 Jun 1989 WO
1991012779 Sep 1991 WO
1992011895 Jul 1992 WO
1992015286 Sep 1992 WO
1993000174 Jan 1993 WO
1993015682 Aug 1993 WO
1994021308 Sep 1994 WO
1994021309 Sep 1994 WO
1995003036 Feb 1995 WO
1997010011 Mar 1997 WO
1997037640 Nov 1997 WO
1998017331 Apr 1998 WO
1998032474 Jul 1998 WO
1999001114 Jan 1999 WO
1998058690 Mar 1999 WO
1999036071 Jul 1999 WO
1999038546 Aug 1999 WO
1999055396 Nov 1999 WO
2000001322 Jan 2000 WO
2000002564 Jan 2000 WO
2000012163 Mar 2000 WO
2000021584 Apr 2000 WO
2001021326 Mar 2001 WO
2001032382 May 2001 WO
2001078626 Oct 2001 WO
2001094103 Dec 2001 WO
2002009786 Feb 2002 WO
2002020174 Mar 2002 WO
2003004072 Jan 2003 WO
2003024615 Mar 2003 WO
2004028579 Apr 2004 WO
2004028699 Apr 2004 WO
2004037126 May 2004 WO
2004037443 May 2004 WO
2004073885 Sep 2004 WO
2004091682 Oct 2004 WO
2004098565 Nov 2004 WO
2005009297 Feb 2005 WO
2006110366 Oct 2006 WO
2007059144 May 2007 WO
2007100801 Sep 2007 WO
2008002357 Jan 2008 WO
2009132214 Oct 2009 WO
2010024898 Mar 2010 WO
2010146096 Dec 2010 WO
2013181498 Dec 2013 WO
2014066760 May 2014 WO
2014182833 Nov 2014 WO
Non-Patent Literature Citations (85)
Entry
Braun, Dietrich “Plastics,” Concise Encyclopedia of Polymer Science and Engineering, 1990 (pp. 461-464).
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 13729853.5 dated Apr. 30, 2018 (6 pages).
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 13792526.9 dated Apr. 19, 2018 (5 pages).
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 13792526.9 dated Aug. 6, 2019 (5 pages).
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 13792526.9 dated Nov. 29, 2018 (4 pages).
“Communication Pursuant to Rule 164(2)(b) and Article 94(3) EPC,” for European Patent Application No. 14730319.2 dated Sep. 4, 2017 (12 pages).
“Communication Pursuant to Rules 161 and 162 EPC,” for European Patent Application No. 13729853.5, dated Feb. 13, 2015 (2 pages).
“Communication Pursuant to Rules 161(1) and 162 EPC,” for European Application No. 13792526.9, dated Jul. 7, 2015 (2 pages).
“Communication Pursuant to Rules 161(1) and 162 EPC,” for European Patent Application No. 14730319.2, dated Dec. 22, 2015 (2 pages).
“Complete File History,” for U.S. Appl. No. 10/371,043 downloaded Jul. 8, 2015 (222 pages).
“Complete File History,” for U.S. Appl. No. 10/409,434 downloaded Jul. 8, 2015 (199 pages).
“Complete File History,” for U.S. Appl. No. 10/976,193, downloaded Jul. 8, 2015 (446 pages).
“Complete File History,” for U.S. Appl. No. 10/976,348 downloaded Jul. 8, 2015 (219 pages).
“Complete File History,” for U.S. Appl. No. 11/102,465 downloaded Jul. 8, 2015, (500 pages).
“Complete File History,” for U.S. Appl. No. 11/375,487 downloaded Jul. 8, 2015 (301 pages).
“Complete File History,” for U.S. Appl. No. 11/421,637 downloaded Jul. 8, 2015 (193 pages).
“Complete File History,” for U.S. Appl. No. 11/539,443 downloaded Jul. 8, 2015, (269 pages).
“Complete File History,” for U.S. Appl. No. 11/559,817 downloaded Jul. 8, 2015 (302 pages).
“Complete File History,” for U.S. Appl. No. 11/823,055 downloaded Jul. 8, 2015, (156 pages).
“Complete File History,” for U.S. Appl. No. 12/109,139 downloaded Dec. 18, 2017 (276 pages).
“Complete File History,” for U.S. Appl. No. 12/980,920 downloaded Jul. 8, 2015 (141 pages).
“Complete File History,” for U.S. Appl. No. 13/906,599 downloaded Dec. 18, 2017 (249 pages).
“Complete File History,” for U.S. Appl. No. 14/063,124 downloaded Dec. 18, 2017 (174 pages).
“Complete File History,” for U.S. Appl. No. 14/272,204 downloaded Dec. 18, 2017 (302 pages).
“Complete File History,” for U.S. Appl. No. 15/061,234 downloaded Apr. 9, 2020 (118 pages).
“Complete File History,” for U.S. Appl. No. 15/783,554 downloaded Apr. 9, 2020 (107 pages).
“Complete File History,” for U.S. Appl. No. 16/160,425 downloaded Apr. 9, 2020 (131 pages).
“Cross-Link,” http://en.wikipedia.org/wiki/Cross-link; retrieved Nov. 6, 2009 (4 pages).
Di Mario, et al., “Radioactive Stents—A Dead End?,” Current Interventional Cardiology Reports, 2000 (2 pages), 87-88.
“European Examination Report,” for European Application No. 04 711 809.6 dated Jan. 23, 2006 (4 pages).
“European Examination Report,” for European Application No. 04 759 211.8 dated Aug. 7, 2006 (5 pages).
“European Examination Report,” for European Application No. 06740366.7 dated Oct. 19, 2010 (4 pages).
“European Examination Report,” for European Application No. 06740366.7, dated May 5, 2009 (4 pages).
“European Search Report,” for European Patent Application No. 19174997.7 dated Sep. 10, 2019 (9 pages).
“Final Office Action,” for Japanese Application No. 2006-509776, dated Jul. 5, 2011, (7 pages).
“Final Office Action,” for Japanese Patent Application No. 2015-539837 dated Oct. 1, 2018 (7 pages) with English Translation.
“Final Rejection,” for Japanese Patent Application No. 2015-515223 dated Nov. 22, 2017 (8 pages) with English translation.
“First Examination Report,” for Costa Rican Patent Application No. 2014-0589 dated May 19, 2019 (2 pages) No English Translation.
“First Office Action,” for CA Application No. 2604832, dated Mar. 16, 2012 (4 pages).
“First Office Action,” for Japanese patent Application No. 2006-503609, dated Mar. 30, 2010 (7 pages) with English translation.
Hiemenz, Paul “Polymer Chemistry: The Basic Concepts,” CRC Press, 1984 (pp. 9 and 12).
“International Preliminary Report on Patentability,” for International Application No. PCT/US2005/038628 dated May 10, 2007 (10 pages).
“International Preliminary Report on Patentability,” For PCT Application No. PCT/US2013/043547, dated Dec. 11, 2014 (7 pages).
“International Preliminary Report on Patentability,” for PCT/US2013/066810, dated May 7, 2015 (12 pages).
“International Preliminary Report on Patentability,” for PCT/US2014/037179 dated Nov. 19, 2015 (9 pages).
“International Preliminary Report on Patentability,” from International Application No. PCT/US2004/004486, dated Aug. 19, 2005, (6 pages).
“International Search Report & Written Opinion,” for PCT/US2004/010692, dated Jul. 23, 2004 (9 pages).
“International Search Report and Written Opinion,” For International Application No. PCT/US2005/038628 dated Mar. 22, 2006 (16 pages).
“International Search Report and Written Opinion,” For PCT Application No. PCT/US2014/037179 dated Feb. 19, 2015 (15 pages).
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2019/063311 dated Mar. 19, 2020 (13 pages).
“International Search Report and Written Opinion,” for PCT/US2006/044218, dated Mar. 22, 2007 (12 pages).
“International Search Report and Written Opinion,” for PCT/US2009/041575, dated Jul. 22, 2009 (15 pages).
“International Search Report and Written Opinion,” for PCT/US2013/043547, dated Oct. 1, 2013 (10 pages).
“International Search Report and Written Opinion,” for PCT/US2013/066810, dated Apr. 17, 2014 (18 pages).
“International Search Report,” for PCT/US2004/004486, dated Jul. 19, 2004 (8 pages).
“Invitation to Pay Additional Fees and, Where Applicable, Protest Fee,” for PCT/US2013/066810, dated Feb. 7, 2014 (6 pages).
“Invitation to Pay Additional Fees,” For PCT Application No. PCT/US2014/037179, dated Oct. 24, 2014 (5 pages).
“Notice of Allowance Received,” for Japanese Application No. 2006-509776, dated Dec. 1, 2011, (4 pages) including English translation.
“Office Action Response,” for Canadian Patent Application No. 2,889,062 filed Mar. 9, 2020 (18 pages).
“Office Action,” for Canadian Patent Application No. 2,874,824 dated Apr. 11, 2019 (5 pages).
“Office Action,” for Canadian Patent Application No. 2,874,824 dated Jan. 9, 2020 (4 pages).
“Office Action,” for Canadian Patent Application No. 2,889,062 dated Sep. 12, 2019 (3 pages).
“Office Action,” for Japanese Patent Application No. 2015-515223 dated Feb. 21, 2019 (5 pages) with English Translation.
“Office Action,” for Japanese Patent Application No. 2015-515223 dated Mar. 24, 2017 (10 pages) with English translation.
“Office Action,” for Japanese Patent Application No. 2015-539837 dated Aug. 31, 2017 (11 pages) with English translation.
“Office Action,” for Japanese Patent Application No. 2015-539837 dated Jun. 28, 2018 (7 pages) with English translation.
“Office Action,” for Japanese Patent Application No. 2016-513047 dated Mar. 6, 2018 (11 pages) with English translation.
“Office Action,” for Mexican Patent Application No. MX/a/2014/014574 dated Jun. 15, 2017 (1 page), English summary.
“Partial File History,” for U.S. Appl. No. 14/063,113 downloaded Apr. 9, 2020 (409 pages).
“Pre-Appeal Examination Report,” for Japanese Patent Application No. 2015-515223 dated Apr. 3, 2018 (5 pages).
“Pre-Appeal Examination Report,” for Japanese Patent Application No. 2015-539837 dated Mar. 8, 2019 (2 pages), no translation available.
“Response to Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 13729853.5, filed with the EPO Sep. 6, 2018 (12 pages).
“Response to Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 13792526.9 filed Dec. 3, 2019 (9 pages).
“Response to Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 13792526.9 filed Mar. 13, 2019 (6 pages).
“Response to Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 13792526.9 filed with the EPO Aug. 17, 2018 (60 pages).
“Response to Communication Pursuant to Rule 164(2)(b) and Article 94(3) EPC,” for European Patent Application No. 14730319.2 filed with the EPO Jan. 2, 2018 (19 pages).
“Response to Communication Pursuant to Rules 161 and 162 EPC,” for European Patent Application No. 13729853.5, filed with the EPO Aug. 13, 2015 (21 pages).
“Response to Communication Pursuant to Rules 161 (1) and 162 EPC,” for European Patent Application No. 13792526.9, dated Jul. 7, 2015 and filed with the EPO Jan. 7, 2016 (18 pages).
“Response to Communication Pursuant to Rules 161 (1) and 162 EPC,” for European Patent Application No. 14730319.2, filed with the EPO Jun. 24, 2016 (11 pages).
“Response to European Examination Report,” for European Application No. 06740366.7, filed Feb. 22, 2011 (8 pages).
“Response to Office Action,” for Canadian Patent Application No. 2,874,824 filed Oct. 7, 2019 (18 pages).
“Response to Search Report,” for European Patent Application No. 19174997.7 filed Mar. 31, 2020 (30 pages).
“Ultrasonic Spray Nozzle Systems,” SONO-TEK Corporation Brochure, 2005 (16 pages).
Yeo, Yoon “A New Microencapsulation Method Using an Ultrasonic Atomizer Based on Interfacial Solvent Exchange,” Journal of Controlled Release 100 (2004) pp. 379-388. 2004.
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2019/063311 dated Jun. 10, 2021 (9 pages).
Related Publications (1)
Number Date Country
20200171531 A1 Jun 2020 US
Provisional Applications (1)
Number Date Country
62772673 Nov 2018 US